Advertisement

Manual of Biological Markers of Disease

  • W. J. van Venrooij
  • R. N. Maini

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Introduction

    1. Front Matter
      Pages 1-2
    2. R. Verheijen, M. Salden, W. J. van Venrooij
      Pages 37-61
    3. E. M. Tan, C. L. Peebles
      Pages 87-99
    4. G. Zieve, M. Fury, E. J. R. Jansen
      Pages 101-113
    5. R. Smeenk
      Pages 115-126
    6. A. Wiik, N. Rasmussen, J. Wieslander
      Pages 127-140
    7. T. E. W. Feltkamp
      Pages 149-159
  3. Introduction to Section B

    1. Front Matter
      Pages 165-166
    2. Autoantigens in Rheumatoid Arthritis (RA)

      1. Rizgar A. Mageed
        Pages 167-193
      2. Jean-Marie Berthelot, Christian Vincent, Guy Serre, Pierre Youinou
        Pages 195-203
      3. David G. Williams
        Pages 215-232
      4. Christian Vincent, Jean-Marie Berthelot, Pierre Youinou, Guy Serre
        Pages 233-244
    3. Autoantigens in Systemic Lupus Erythematosus (SLE)

      1. Ruud J. T. Smeenk
        Pages 245-259
      2. Rufus W. Burlingame, Robert L. Rubin
        Pages 261-288
      3. Sylviane Muller
        Pages 289-298
      4. Sallie O. Hoch
        Pages 301-329
      5. Keith B. Elkon
        Pages 331-341
      6. Westley H. Reeves, Minoru Satoh, Jingsong Wang, Ajay K. Ajmani
        Pages 343-364
      7. Yoshinao Muro, Eng M. Tan
        Pages 365-376
      8. E. Nigel Harris
        Pages 377-390
    4. Autoantigens in SLE-overlap syndromes

      1. Jacqueline M. T. Klein Gunnewiek, Jacqueline Walther J. van Venrooij
        Pages 391-410
    5. Autoantigens in Sjögren’ syndrome

      1. Edward K. L. Chan, Jill P. Buyon
        Pages 411-428
      2. Ger J. M. Pruijn
        Pages 429-442
    6. Autoantigens in Scleroderma

      1. R. Verheijen
        Pages 443-458
      2. Ron Verheijen
        Pages 459-475
      3. Ron Verheijen
        Pages 477-486
      4. Friedlinde A. Bautz, Martin Blüthner
        Pages 487-503
    7. Autoantigens in Myositis

    8. Autoantigens in Vasculitis

      1. Jörgen Wieslander, Allan Wiik
        Pages 523-531
      2. Jörgen Wieslander, Allan Wiik
        Pages 533-541
    9. Autoantigens in other diseases

      1. Patrick S. C. Leung, Ian Mackay, M. Eric Gershwin
        Pages 543-556
      2. Maria Carmo-Fonseca, Kerstin Bohmann, Maria Teresa Carvalho, Angus I. Lamond
        Pages 557-567
  4. Introduction to Section C

    1. Front Matter
      Pages 571-572
    2. Autoantibodies in rheumatoid arthritis

      1. Josef S. Smolen
        Pages 573-590
    3. Autoantibodies in SLE

      1. A. J. G. Swaak, R. J. T. Smeenk
        Pages 591-607
      2. Robert Bernstein
        Pages 609-615
      3. Westley H. Reeves, Minoru Satoh, Jenifer J. Langdon
        Pages 617-627
      4. Yoshinari Takasaki, E. M. Tan
        Pages 629-641
      5. Vanessa Morris, Charles Mackworth-Young
        Pages 643-656
    4. Autoantibodies in SLE-overlap syndromes

      1. Frank H. J. Van Den Hoogen, Levinus B. A. Van De Putte
        Pages 657-664
    5. Autoantibodies in Sjögren’s syndrome

      1. A. G. Tzioufas, H. M. Moutsopoulos
        Pages 665-678
    6. Autoantibodies in Scleroderma

      1. Naomi F. Rothfield
        Pages 679-685
    7. Autoantibodies in Myositis

      1. Ira N. Targoff, Paul H. Plotz
        Pages 687-698

About this book

Introduction

A comprehensive reference work:
This looseleaf work is an authoritative compilation of methods for the detection of autoantibodies (Section A: Methods of Autoantibody Detection); the structure, function, and molecular and biochemical concepts of autoantigens (Section B: Autoantigens); and the clinical significance of measuring autoantibodies in patients with rheumatic, connective tissue and autoimmune diseases (Section C: Clinical Significance of Autoantibodies).
This unique work brings together all the molecular and medical information - very difficult to retrieve otherwise - in ONE publication. The Editors and contributors are leading experts in the immunological, molecular biological, and clinical fields.
The format of this looseleaf publication allows regular updating of data as well as inclusion of new advances in research on autoimmunity. Until now, the work (Basic work including Supplement 1) included Section A, and the larger part of Section B, both in an attractive and robust ringbinder.
Audience: By nature and design of this exciting reference work, it is especially aimed at scientists, including immunologists, pathologists and molecular biologists, and clinical chemists, as well as clinicians specializing in rheumatic diseases and autoimmune disorders, inflammation or clinical immunology.
Supplement 2: This supplement primarily contains Section C (Clinical Significance of Autoantibodies). As in the other sections, the contents are presented in a consistently structured manner, beautifully illustrated with photos and schematic figures. Extensive literature references are provided.
Also, this supplement includes an addition to Section B (Autoantigens), being chapter B.1.5: The Antigens Defined by Antikeratin Antibodies (AKA).

Keywords

Antigen Arthritis DNA Laboratory autoimmune disease proteins

Editors and affiliations

  • W. J. van Venrooij
    • 1
  • R. N. Maini
    • 2
  1. 1.University of NijmegenThe Netherlands
  2. 2.The Mathilda and Terence Kennedy Institute of RheumatologyLondonUK

Bibliographic information

  • DOI https://doi.org/10.1007/978-94-011-1670-1
  • Copyright Information Springer Science+Business Media B.V. 1996
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-0-7923-2219-1
  • Online ISBN 978-94-011-1670-1
  • Buy this book on publisher's site